Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Dec 2009 for NEUROGEN CORP.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stewart Hen: trading record in brief
Filings by Stewart Hen span 3 companies, the busiest being Neurogen Corp, Allos Therapeutics Inc and Altus Pharmaceuticals Inc. The record holds 5 filings, for trades running from 31 January 2006 to 23 December 2009.
No open-market sale appears; the market trades are 1 purchase worth €12.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 24 December 2009, the filings show a transaction in Neurogen Corp. The last insider purchase was made public on 30 May 2008, 6,721 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stewart Hen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
13,571,411 sharesCommon Stock, par value $0.025 per shareSEC:0000899140-09-001844:0
4,999,982 sharesCommon Stock, par value $0.025 per shareSEC:0000899140-08-001787:0
4,999,982 sharesCommon Stock, par value $0.025 per shareSEC:0000899140-08-001506:0
3,589,246 sharesCommon StockSEC:0001209191-06-007329:0
4 of 4 declarations
